25459-91-0
[1]Patent:US2005/13788,2005,A1.Locationinpatent:Page/Pagecolumn10
[1]CurrentPatentAssignee:DIGNITYHEALTH-WO2021/162750,2021,A1Locationinpatent:Paragraph0145-0146
[2]CurrentPatentAssignee:XINTRIAPHARMACEUTICAL;XINTRIAPHARMACEUTICALIN-WO2010/104595,2010,A1Locationinpatent:Page/Pagecolumn103
[1]DrugMetabolismandDisposition,2015,vol.43,p.1100-1107
[1]CurrentPatentAssignee:QINGDAOUNIVERSITYOFSCIENCEANDTECHNOLOGY-CN114848818,2022,ALocationinpatent:Paragraph0045-0046
Title: Zhang P, et al. Demethyleneberberine, a natural mitochondria-targeted antioxidant, inhibits mitochondrial dysfunction, oxidative stress, and steatosis in alcoholic liver disease mouse model. J Pharmacol Exp Ther. 2015 Jan;352(1):139-47.
Title: Chen YY, et al. Demethyleneberberine alleviates inflammatory bowel disease in mice through regulating NF-κB signaling and T-helper cell homeostasis. Inflamm Res. 2017 Feb;66(2):187-196.
Title: Qiang X, et al. Demethyleneberberine attenuates non-alcoholic fatty liver disease with activation of AMPK and inhibition of oxidative stress. Biochem Biophys Res Commun. 2016 Apr 15;472(4):603-9.
